 The purpose of the study is to demonstrate the clinical efficacy of abatacept body-weight tiered dose approximating 10 mgkg compared with placebo on a background of methotrexate after 6 months Day 169 of treatment in Korean patients with active rheumatoid arthritis and an inadequate clinical response to methotrexate 